iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.5942
-0.0002 (-0.03%)
At close: Aug 8, 2025, 4:00 PM
0.6000
+0.0058 (0.98%)
After-hours: Aug 8, 2025, 7:58 PM EDT
Blueprint Medicines Market Cap
iBio, Inc. has a market cap or net worth of $9.64 million as of August 8, 2025. Its market cap has decreased by -47.91% in one year.
Market Cap
9.64M
Enterprise Value
9.00M
1-Year Change
-47.91%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since November 16, 2009, iBio, Inc.'s market cap has decreased from $27.70M to $9.64M, a decrease of -65.21%. That is a compound annual growth rate of -6.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 9.80M | -56.25% |
| Dec 31, 2024 | 22.40M | 1,078.95% |
| Dec 29, 2023 | 1.90M | -52.50% |
| Dec 30, 2022 | 4.00M | -96.66% |
| Dec 31, 2021 | 119.70M | -37.40% |
| Dec 31, 2020 | 191.20M | 2,320.25% |
| Dec 31, 2019 | 7.90M | -43.57% |
| Dec 31, 2018 | 14.00M | -14.63% |
| Dec 29, 2017 | 16.40M | -53.41% |
| Dec 30, 2016 | 35.20M | -18.71% |
| Dec 31, 2015 | 43.30M | -12.17% |
| Dec 31, 2014 | 49.30M | 128.24% |
| Dec 31, 2013 | 21.60M | -27.03% |
| Dec 31, 2012 | 29.60M | 10.04% |
| Dec 30, 2011 | 26.90M | -73.23% |
| Dec 31, 2010 | 100.50M | 298.81% |
| Dec 31, 2009 | 25.20M | -9.03% |
| Nov 16, 2009 | 27.70M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |